Industry Experts – Market Research Reports

Industry Experts caters the market research needs of a broad range of industry verticals comprising Automotive, Healthcare, Food & Beverage, Telecom & Internet, Chemicals & Plastics, Biotechnology and Consumer Goods. The company also provides customized market research and industry analysis services for a wide range of industry sectors.

14 Aug

Omics Technologies, Guided by Rapid, Reliable, Precise and Accurate Results, Drives Global Biomarkers Market to Cross $80 Billion by 2025 – Market Report (2018-2025) by Industry Experts, Inc.

Posted in Biotechnology, News on 14.08.19 by IE Admin

Industry Experts, Inc. released an updated 2019 version of its popular global market research report on Biomarkers. The new report “Biomarkers: Discovery Techniques and Applications – A Global Market Overview” explores the market for key biomarker discovery techniques and therapeutic areas/applications. The report estimates the global Biomarkers market at US$3802 billion in 2019.

The factors driving the Biomarkers market growth includes elevated demand for personalized medicine, technological advancement, immense utilization of biomarkers in drug discovery and development procedures, massive research on biomarkers, increasing awareness about role of biomarkers in early disease diagnosis, increase research funding, and many more.

Global market for Biomarkers is dominated by Oncology, in terms of application, estimated at a market share of 41.2% in 2018 and forecast to touch US$15.6 billion in 2019. The overall market for Biomarkers is projected to reach approximately US$50 billion by 2021.

global biomarkers market

The Biomarker Discovery Technologies market analyzed in this report constitutes Omics Technologies, Bioimaging, and Bioinformatics. The Omics technologies market is further drilled down for Proteomics, Genomics, Metabolomics and Others; and Bioimaging’s market further split in to MRI, CT, Ultrasound and Other. The report also focuses on the Biomarkers applications market including Oncology, Cardiology, Neurology and Others.

The report reviews, analyses and projects the Biomarkers market for global and the regional markets including the North America, Europe, Asia-Pacific and Rest of World for the period 2016-2025 in terms of value in USD. These regional markets further analyzed for 13 independent countries across North America – the United States, Canada and Mexico; Europe – Germany, the United Kingdom, France, Italy, Spain and Sweden; Asia-Pacific – China, Japan, India and Australia.

This global Biomarker Discovery Technologies and Applications market report includes 149 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. This report includes the brief business profiles of 37 key global players and 51 major players across the North America – 32; Europe – 17; Asia-Pacific – 1; and Rest of World – 1. The report also provides the listing of the companies engaged in development, supply, custom synthesis services and distribution of Biomarkers discovery technologies, kits, assays, reagents, software, consumables etc. The global list covers the addresses, contact numbers and the website addresses of 225 companies.

California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.

For more details, please visit http://industry-experts.com/verticals/biotechnology/biomarkers-discovery-techniques-and-applications-a-global-market-overview

tags: , , , , , ,

No Comments »

08 Nov

Global Market for Biomarkers to Grow by 18.8% (2010-2020) to touch $63bn

Posted in Chemicals & Plastics, News on 08.11.13 by IE Admin

Industry Experts has today released an updated 2013 version of the market research report on Biomarkers that published back in 2010. The report discusses the global market for Biomarkers by discovery techniques and application areas.

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline, which comprise drug discovery, toxicity, clinical markers of efficacy and therapeutic indicators, development of diagnostic assays and environmental pollutant exposure. The fields of epidemiology and toxicology have also made use of biomarkers in indicating exposure to a range of environmental substances. In such instances, the biomarker could be the substance itself, such as asbestos particles or nicotine-derived nitrosamine ketone (NNK) from tobacco, or a variation of the external substance processed by the body, such as a metabolite. Using biomarkers in species, such as aquatic animals and invertebrates can be helpful in determining levels and ranges of environmental pollutants.

Personalized medicine constitutes another facet that has been in an ever increasing mode, wherein genomic data are utilized for classifying subsets of patients that would respond to a specific line of therapy. The progression of biomarker research in ascertaining the basics of personalized medicine implies that the prospects of jointly developing drugs and biomarkers would be associated with identifying that section of the population that would garner the maximum benefit from that drug treatment. Developing such biomarkers requires expending considerable efforts and resources, which would enable in expanding the tasks accomplished by biomarkers in disease screening as surrogate endpoints and diagnostic indices.

Biomarker discovery techniques analyzed in this report include Bioimaging, Bioinformatics and Omics Technologies. On a broader geographic level, these technologies further drilled down to Bioimaging – Computed Tomography (CT), Magnetic Resonence Imaging (MRI), Ultrasound and Other; and Omics Technologies – Genomics, Metabolomics, Proteomics and Other. The study also explores the global market for therapeutic areas of biomarkers comprising Cardiology, Neurology, Oncology and Other.

The report reviews, analyses and projects the Biomarkers market for global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across Europe – France, Germany, Italy, Spain, Sweden, the United Kingdom; and Asia-Pacific – Australia, China, India and Japan. Accounting for a lion’s share of an estimated 47% in 2013, equating to US$18.9 billion, the United States leads the global market for Biomarkers. Growing at a robust compounded annual growth rate of 18.8% during the period 2013-2020, the global market is projected to touch US$63.2 billion.

This 350 pages, global market report includes 100 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the market value in US$ by geographic region, biomarker discovery techniques and therapeutic area. This report profiles 52 key global players and 70 major players across the United States – 34; Europe – 24; Asia-Pacific – 7 and Rest of World – 5. The research also provides the listing of the companies engaged in research & development, equipment manufacturing and supply of biomarkers. The global list of companies covers addresses, contact numbers and the website addresses of 245 companies.

Hyderabad, India based Industry Experts is a multi industry focused business information provider.

For more details, please visit http://industry-experts.com/verticals/biotechnology/biomarkers-discovery-techniques-and-applications-a-global-market-overview.html

tags: , , , , , ,

No Comments »